TY - JOUR AU - Balicer, Ran AU - Huerta, Michael AU - Davidovitch, Nadav AU - Grotto, Itamar T1 - Cost-Benefit of Stockpiling Drugs for Influenza Pandemic T2 - Emerging Infectious Disease journal PY - 2005 VL - 11 IS - 8 SP - 1280 SN - 1080-6059 AB - We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts. KW - Keywords: antiviral agents KW - disease outbreaks KW - Influenza KW - Prevention and Control KW - Cost-Benefit Analysis KW - Israel DO - 10.3201/eid1108.041156 UR - https://wwwnc.cdc.gov/eid/article/11/8/04-1156_article ER - End of Reference